'Radical cystectomy' presentation slideshows

Urinary Bladder Cancer

Urinary Bladder Cancer. John Crew, M.D., PGY-2 Radiation Oncology Brown Cancer Center, University of Louisville. Outline. Overview Anatomy Etiology/Epidemiology Risk Factors Pathology Clinical Presentation, Diagnosis, Work-up Staging Literature Review Conclusions Questions. Anatomy.

2.23k views • 78 slides

GU Oncology

GU Oncology. Dr. Saleh Binsaleh Assistant Professor and Consultant Urologist. Contents. Renal Tumors Bladder Tumors Prostate Tumors Testis Tumors. Renal Tumors. Renal Tumors. Benign tumours of the kidney are rare All renal neoplasms should be regarded as potentially malignant

1.04k views • 68 slides

A Guide to the Diagnosis, Treatment and Follow-Up of Bladder and Kidney Cancer.

774 views • 48 slides

High-Grade T1 Bladder Cancer: A Clinical Quandary

High-Grade T1 Bladder Cancer: A Clinical Quandary. Daniel Canter, M.D. Assistant Professor of Urology Emory University. presentation created for:. Outline. Background Incidence of High-grade T1 Disease Importance of Re-resection Recurrence and Progression Clinical Understaging

461 views • 45 slides

Dr. Abdellatif Zayed Amzayed_1919@yahoo

Bladder Cancer. Dr. Abdellatif Zayed Amzayed_1919@yahoo.com. Pathology:. Today Objectives. Predisposing Factors Pathologic Types Staging Grading spread. Management:. Clinical features Investigations treatment. Predisposing factors:. Industrial toxins Drugs: e.g. Cyclophosphamide.

433 views • 43 slides

Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass

59 years old man Hx of stomach adenocarcinoma 20 years ago Hx of chemoradiotherapy cc:gross hematuria. Cytology:doubtful malignancy PSA: 4.9 5.5 Cr: 1.1 USG: Bladder mass TURBT&PROSTATE Bx was done. Bladder :High grade TCC+CIS prostate :GS 3+4. GI biopsy :NL.

392 views • 26 slides

RENAL TUMORS

964 views • 25 slides

RENAL TUMORS

729 views • 25 slides

RENAL TUMORS

307 views • 25 slides

Follow-up for GU Malignancies

Follow-up for GU Malignancies. David Kim Radiation Oncologist BCCA - Southern Interior. Follow-up of GU Malignancies. Objectives rationale, aim, and details of general follow-up general BCCA guidelines and position follow-up of specific GU sites low risk seminoma

370 views • 23 slides

Urostomy Why?

630 views • 22 slides

Bladder cancer is the second most common cancer of the genitourinary tract.

Bladder cancer is the second most common cancer of the genitourinary tract. The incidence is higher in whites than in African Americans. The average age at diagnosis is 65 years. Cigarette smoking accounts for 50% of cases in men and31% in women Occupational exposure

203 views • 20 slides

??? ???? ??????? ???????

??? ???? ??????? ???????. H. Emama M.D. Bladder Cancer. (Radiation Therapy) By: H. Emami Assistant professor of Radiation Oncology, Isfahan University of Medical Sciences, Isfahan, IRAN. Bladder Cancer. Superficial tumors TUR (standard).

371 views • 16 slides

Abid Hussain MBBS Mentor: Khurshid A. Guru. MD

SHORT-TERM PATIENT REPORTED QUALITY OF LIFE AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY USING THE CONVALESCENCE AND RECOVERY EVALUATION (CARE). Abid Hussain MBBS Mentor: Khurshid A. Guru. MD. INTRODUCTION.

324 views • 16 slides

Abid Hussain MBBS Mentor: Khurshid A. Guru. MD

SHORT-TERM PATIENT REPORTED QUALITY OF LIFE AFTER ROBOT-ASSISTED RADICAL CYSTECTOMY USING THE CONVALESCENCE AND RECOVERY EVALUATION (CARE). Abid Hussain MBBS Mentor: Khurshid A. Guru. MD. INTRODUCTION.

290 views • 16 slides

OPERTATIONS OF KIDNEY

OPERTATIONS OF KIDNEY. OPEN PYELOLITHOTOMY 6 DAYS PYELOPLASTY 7 DAYS ENDOPYELOTOMY 4-5 DAYS NEPHRECTOMY 7-8 DAYS RADICAL NEPHRECTOMY 7-8 DAYS LAP NEPHRECTOMY 3-5 DAYS CHYLURIA 2-3 DAYS. UPPER URETER

105 views • 10 slides

The long term outcome of high risk non-muscle invasive bladder cancer.

The long term outcome of high risk non-muscle invasive bladder cancer. F Thomas , N Rubin, J Goepel, D Rosario, MF Abbod, JWF Catto. Academic unit of Urology, Sheffield Teaching Hospitals, Sheffield. Retrospective study of patients 1994-2009 High risk NMIBC(G3Ta,G3T1,(G1,G2T1),CIS)

258 views • 7 slides

Radical c ystectomy: The benefit of l ymph n ode density .

No. 113. Radical c ystectomy: The benefit of l ymph n ode density . Athina Pirpiris, Kathryn Rzetelski -West, Jeremy Grummet The Alfred Hospital, Melbourne. Posters Proudly Supported by: . Introduction

146 views • 1 slides

Indications and pathological outcomes of radical cystectomy

No. 074. Indications and pathological outcomes of radical cystectomy. Stephanie Kerr, Prassannah Satasivam , Jeremy Grummet The Alfred Hospital, Prahran VIC. Introduction

202 views • 1 slides

Table 1 Results of radical cystectomy

Table 1 Results of radical cystectomy. Ghoneim MA and Abol-Enein H (2008) Management of muscle-invasive bladder cancer: an update Nat Clin Pract Urol doi:10.1038/ ncpuro1202.

224 views • 1 slides